Neurology · 2007 · 263 citations · 14 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeuroimmunologyNeuropharmacologyAmyloid FormationBiomarkers Of NeurodegenerationCerebrospinal Fluid BiomarkersDementia BiomarkersFluctuation AnalysisNeurodegenerative DiseasesAmyloid Aggregation KineticsAmyloid Beta PeptidesAmyloidogenic ProteinsCsf-to-blood Biomarker RatiosTherapeutic Trials
OBJECTIVE: To investigate the stability and time course of human CSF amyloid-beta (Abeta) levels over hours. METHODS: Fifteen nondemented participants had CSF sampled hourly for up to 36 hours via indwelling lumbar catheter. CSF Abeta(1-x), Abeta(1-40), and Abeta(1-42) were measured by ELISA in each hourly CSF sample. RESULTS: Significant variation in Abeta levels of 1.5- to fourfold was detected over 36 hours of serially sampling in individual subjects. Abeta(40), Abeta(42), and Abeta(1-X) are highly correlated over time indicating that similar processes likely regulate the level of these species. On average, the fluctuations of Abeta levels appear to be time of day or activity dependent. CONCLUSION: Diagnostic and therapeutic trials that measure Abeta should control for the time of CSF sampling to minimize variability.
14
APP Processing and Synaptic Function
Flavio Kamenetz, Taisuke Tomita, Helen Hsieh et al. · Neuron · 2003 · 1.6K citations · Full text
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
John R. Cirrito, Kelvin A. Yamada, Mary Beth Finn et al. · Neuron · 2005 · 1.3K citations · Full text